Afshin Samali Selected Research

Afshin Samali Research Topics

Disease

23	Neoplasms (Cancer) 09/2021 - 06/2006
9	Necrosis 07/2016 - 12/2003
8	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 01/2018
7	Hypoxia (Hypoxemia) 01/2021 - 12/2003
5	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2018
5	Ischemia 01/2014 - 12/2003
4	Parkinson Disease (Parkinson's Disease) 03/2023 - 12/2003
3	Triple Negative Breast Neoplasms 01/2022 - 01/2018
3	Inflammation (Inflammations) 12/2019 - 11/2013
2	Disease Progression 01/2021 - 01/2019
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 01/2015
2	Carcinoma (Carcinomatosis) 09/2011 - 04/2010
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2022
1	Neoplasm Metastasis (Metastasis) 09/2021
1	Idiopathic Pulmonary Fibrosis 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 10/2020
1	Rhabdomyosarcoma 10/2020
1	Mast-Cell Leukemia (Leukemia, Mast Cell) 01/2019
1	Fibrosis (Cirrhosis) 01/2018
1	Chronic Pain 01/2018
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Infections 12/2015
1	Philadelphia Chromosome 01/2015
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2015
1	Hyperglycemia 01/2014
1	Heart Diseases (Heart Disease) 01/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2014
1	Acidosis 01/2014
1	Starvation 10/2013
1	Virus Diseases (Viral Diseases) 10/2013
1	Multiple Myeloma 06/2013
1	Shock 12/2012
1	Hypersensitivity (Allergy) 11/2012
1	Neuroinflammatory Diseases 10/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2011
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2011
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2011

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 09/2021 - 05/2009
9	LigandsIBA 01/2020 - 06/2006
6	Death Domain ReceptorsIBA 11/2013 - 06/2006
6	CaspasesIBA 11/2013 - 12/2003
4	Temozolomide (Temodar)FDA LinkGeneric 04/2024 - 01/2018
4	Ribonucleases (Ribonuclease)IBA 02/2023 - 01/2018
4	Oxygen (Dioxygen)IBA 11/2022 - 11/2006
4	Glucose (Dextrose)FDA LinkGeneric 01/2014 - 11/2006
3	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 05/2009 - 06/2006
2	Simvastatin (Zocor)FDA LinkGeneric 04/2024 - 10/2020
2	CytokinesIBA 01/2021 - 05/2009
2	Inositol (Myoinositol)IBA 01/2021 - 10/2018
2	EnzymesIBA 01/2021 - 10/2018
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 03/2009
2	Protein Kinases (Protein Kinase)IBA 12/2019 - 11/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 01/2018
2	Nerve Growth Factor (NGF)IBA 01/2018 - 12/2006
2	AntibodiesIBA 12/2015 - 05/2009
2	Caspase 3 (Caspase-3)IBA 12/2015 - 03/2009
2	MicroRNAs (MicroRNA)IBA 01/2014 - 01/2013
2	Small Interfering RNA (siRNA)IBA 11/2012 - 07/2006
2	Antineoplastic Agents (Antineoplastics)IBA 03/2009 - 07/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2008 - 06/2006
2	Dexamethasone (Maxidex)FDA LinkGeneric 05/2007 - 07/2006
2	Oxidopamine (6 Hydroxydopamine)IBA 12/2006 - 02/2005
2	NeurotoxinsIBA 02/2005 - 12/2003
1	Biomarkers (Surrogate Marker)IBA 03/2023
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	MKC8866IBA 12/2020
1	Benzoates (Benzoate)IBA 01/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	OxalatesIBA 01/2020
1	hydroxide ionIBA 01/2020
1	1,2-cyclohexanediamine (dach)IBA 01/2020
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 12/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	KIRA6IBA 01/2019
1	7- methyl- 5- (1- ((3- (trifluoromethyl)phenyl)acetyl)- 2,3- dihydro- 1H- indol- 5- yl)- 7H- pyrrolo(2,3- d)pyrimidin- 4- amineIBA 01/2019
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 01/2018
1	CollagenIBA 01/2018
1	Alkylating AgentsIBA 01/2018
1	Fibronectins (Fibronectin)IBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2016
1	Endoplasmic Reticulum Chaperone BiPIBA 12/2015
1	Phosphotransferases (Kinase)IBA 01/2015
1	CalciumIBA 01/2014
1	Amino Acids FDA Link 11/2013
1	MitogensIBA 11/2013
1	Nerve Growth Factors (Neurotrophins)IBA 11/2013
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 11/2013
1	Type I Tumor Necrosis Factor ReceptorsIBA 11/2013
1	TNF-Related Apoptosis-Inducing LigandIBA 11/2013
1	Ectodysplasin ReceptorsIBA 11/2013
1	Serine (L-Serine)FDA Link 10/2013
1	Proteasome InhibitorsIBA 06/2013
1	ProteomeIBA 12/2012
1	Free RadicalsIBA 10/2011
1	Glutamic Acid (Glutamate)FDA Link 10/2011
1	fucoidanIBA 09/2011

Therapy/Procedure

15	Therapeutics 09/2021 - 06/2006
6	Drug Therapy (Chemotherapy) 01/2021 - 01/2018